Scilex Holding Co
Develops and commercializes pharmaceutical products for the treatment of chronic pain and cancer.
Stock Performance Snapshot
Analyst Rating
Analysts suggest keeping Scilex's stock as it may not significantly rise or fall soon.
Financial Health
Scilex Holding Co is performing well with solid revenue and profit margins, indicating healthy operations.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring SCLX
Executive Conviction In The GLP-1 Market
Following a stock drop from a clinical trial setback, Eli Lilly executives made significant share purchases, signaling strong belief in the company's future. This insider confidence highlights a potential investment opportunity in the rapidly growing and competitive GLP-1 weight-loss drug market.
Published: August 13, 2025
Explore BasketBeyond Opioids: The Race For New Painkillers
Vertex Pharmaceuticals has halted the development of its non-opioid painkiller, creating uncertainty but also a potential opening for competitors. This theme focuses on other pharmaceutical companies that could capture market share as they advance their own non-opioid treatments.
Published: August 5, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline Catalysts
Clinical readouts and regulatory steps can be primary value drivers; timing of results often drives short‑term moves, though outcomes can vary.
Small‑cap Volatility
With a market cap near $102M, the stock can be more volatile and less liquid than larger peers, so position size and risk management matter.
Regulatory Watch
Approvals, label changes or partnerships influence commercial prospects; regulatory uncertainty is a standard risk in this sector.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
